Younger patients often require repeat corneal crosslinking, study finds

Dinah Zur, MD, shares insights from her International SPECTRALIS Symposium lecture

Cabozantinib, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, has previously been associated with hepatic and dermatologic adverse effects

Research findings from the multicentre clinical study were presented at the European Society of Ophthalmology (SOE) meeting in Lisbon, Portugal

The 0.1 mg/ml atropine eye drop for paediatric myopia is licensed from Sydnexis, Inc.

The study found an increase in both refractive astigmatism and corneal astigmatism among a patient population of schoolchildren

The investigational device, ETX-4143, was the focus of a study involving 31 patients with COSP in Australia